Institutional investors hold a majority ownership of THOR through the 96.58% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended September 2014, these large investors purchased a net $2.7 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STATE STREET GLOBAL ADVISORS LTD... Bought 340.7 Thousand shares of Thoratec Corp
EAGLE ASSET MANAGEMENT, INC. Bought 304.4 Thousand shares of Thoratec Corp